Kaley McNabb
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (38.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Endo USA, Inc. accounts for 82.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $1,740 and has fallen 98.7% since, to $23 in 2025.
Across 22 payments — averaging $95.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo USA, Inc.$2K
- Endo Pharmaceuticals Inc.$242
- Stryker$62
- MVP Orthopedics Inc$27
- Bioventus LLC$19
- Smith+Nephew$13
- plus $11 from 1 others
What the payments were for
- Consulting fees$70033%
- Travel & lodging$80838%
- Food & beverage$60329%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endo USA, Inc. | 9 | $1,737 |
| Endo Pharmaceuticals Inc. | 7 | $242 |
| Stryker | 2 | $62 |
| MVP Orthopedics Inc | 1 | $27 |
| Bioventus LLC | 1 | $19 |
| Smith+Nephew | 1 | $13 |
| Daxor Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIAFLEX$1,596
How this compares
$2,111 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 67 | $563 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $212 |
| Tramadol Hcl | 44 | $115 |
| Doxycycline Hyclate | 14 | $101 |
| Gabapentin | 17 | $41 |
| Meloxicam | 17 | $27 |
Paid to pharmacies, not to this prescriber.
Other family in Tampa
- Lewis HarringtonTampa$954K
- Marie Labadie-DegennaroTampa$66K
- Polly BittleTampa$63K
- Katharine WilliamsTampa$47K
- Candace DeberryTampa$46K
- Bailey BlankenshipTampa$42K
- Rasheeta ChandlerTampa$37K
- Rosaly TorresTampa$28K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.